Cargando…

Drugs to Treat Alcohol Dependence-A Perspective

Despite increased awareness, prevention campaigns, and tighter laws and regulations, alcohol consumption caused an average of 88,000 deaths per year and a burden of $249 billion to the U.S economy in 2010. Only three FDA-approved drugs, disulfiram, naltrexone and acamprosate are available for the tr...

Descripción completa

Detalles Bibliográficos
Autor principal: Das, Joydip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945284/
https://www.ncbi.nlm.nih.gov/pubmed/29756083
_version_ 1783321971993346048
author Das, Joydip
author_facet Das, Joydip
author_sort Das, Joydip
collection PubMed
description Despite increased awareness, prevention campaigns, and tighter laws and regulations, alcohol consumption caused an average of 88,000 deaths per year and a burden of $249 billion to the U.S economy in 2010. Only three FDA-approved drugs, disulfiram, naltrexone and acamprosate are available for the treatment of alcohol use disorder. These drugs are only effective modestly and patient compliance is a serious issue because of several adverse side effects, necessitating the developments of newer drugs. The current research drug development efforts remains in the identification new alcohol targets and elucidating the molecular mechanism of its action is needed for effective intervention. In addition, current treatment could be improved by testing the existing medications for comorbid conditions using the patient’s genetic background information.
format Online
Article
Text
id pubmed-5945284
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-59452842018-05-10 Drugs to Treat Alcohol Dependence-A Perspective Das, Joydip J Addict Depend Article Despite increased awareness, prevention campaigns, and tighter laws and regulations, alcohol consumption caused an average of 88,000 deaths per year and a burden of $249 billion to the U.S economy in 2010. Only three FDA-approved drugs, disulfiram, naltrexone and acamprosate are available for the treatment of alcohol use disorder. These drugs are only effective modestly and patient compliance is a serious issue because of several adverse side effects, necessitating the developments of newer drugs. The current research drug development efforts remains in the identification new alcohol targets and elucidating the molecular mechanism of its action is needed for effective intervention. In addition, current treatment could be improved by testing the existing medications for comorbid conditions using the patient’s genetic background information. 2016-06-06 2016 /pmc/articles/PMC5945284/ /pubmed/29756083 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
spellingShingle Article
Das, Joydip
Drugs to Treat Alcohol Dependence-A Perspective
title Drugs to Treat Alcohol Dependence-A Perspective
title_full Drugs to Treat Alcohol Dependence-A Perspective
title_fullStr Drugs to Treat Alcohol Dependence-A Perspective
title_full_unstemmed Drugs to Treat Alcohol Dependence-A Perspective
title_short Drugs to Treat Alcohol Dependence-A Perspective
title_sort drugs to treat alcohol dependence-a perspective
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945284/
https://www.ncbi.nlm.nih.gov/pubmed/29756083
work_keys_str_mv AT dasjoydip drugstotreatalcoholdependenceaperspective